- Home
- REBN vs PTHL Comparison
REBN vs PTHL Comparison
Compare REBN & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REBN
- PTHL
- Stock Information
- Founded
- REBN 2015
- PTHL 1998
- Country
- REBN United States
- PTHL China
- Employees
- REBN N/A
- PTHL N/A
- Industry
- REBN Restaurants
- PTHL
- Sector
- REBN Consumer Discretionary
- PTHL
- Exchange
- REBN Nasdaq
- PTHL Nasdaq
- Market Cap
- REBN 15.3M
- PTHL 13.5M
- IPO Year
- REBN 2022
- PTHL 2024
- Fundamental
- Price
- REBN $2.45
- PTHL $1.03
- Analyst Decision
- REBN
- PTHL
- Analyst Count
- REBN 0
- PTHL 0
- Target Price
- REBN N/A
- PTHL N/A
- AVG Volume (30 Days)
- REBN 93.6K
- PTHL 1.9M
- Earning Date
- REBN 08-14-2025
- PTHL 01-01-0001
- Dividend Yield
- REBN N/A
- PTHL N/A
- EPS Growth
- REBN N/A
- PTHL N/A
- EPS
- REBN N/A
- PTHL N/A
- Revenue
- REBN $6,565,623.00
- PTHL $448,196.00
- Revenue This Year
- REBN $335.98
- PTHL N/A
- Revenue Next Year
- REBN N/A
- PTHL N/A
- P/E Ratio
- REBN N/A
- PTHL N/A
- Revenue Growth
- REBN 14.03
- PTHL N/A
- 52 Week Low
- REBN $1.03
- PTHL $0.51
- 52 Week High
- REBN $8.30
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- REBN 34.79
- PTHL 30.42
- Support Level
- REBN $2.91
- PTHL $0.70
- Resistance Level
- REBN $3.24
- PTHL $1.18
- Average True Range (ATR)
- REBN 0.19
- PTHL 0.14
- MACD
- REBN -0.06
- PTHL 0.69
- Stochastic Oscillator
- REBN 10.91
- PTHL 77.78
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.